<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[NOVO — December 2025]]></title><description><![CDATA[<p dir="auto">Novo-aktien slutter volatil måned med et hav af nyheder stort set uændret <a href="https://proinvestor.com/investornyt/1388264/novo-aktien-slutter-volatil-maned-med-et-hav-af-nyheder-stort-set-uaendret" rel="nofollow ugc">https://proinvestor.com/investornyt/1388264/novo-aktien-slutter-volatil-maned-med-et-hav-af-nyheder-stort-set-uaendret</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/400328/novo-december-2025</link><generator>RSS for Node</generator><lastBuildDate>Sat, 06 Jun 2026 05:03:28 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/400328.rss" rel="self" type="application/rss+xml"/><pubDate>Mon, 01 Dec 2025 05:20:03 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to NOVO — December 2025 on Wed, 31 Dec 2025 13:11:53 GMT]]></title><description><![CDATA[<p dir="auto">Så det er en længerevarende tvist, som kunne have været dyrt for os, men patentet udløber jo alligevel i 2026.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988247</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988247</guid><dc:creator><![CDATA[Craw]]></dc:creator><pubDate>Wed, 31 Dec 2025 13:11:53 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Wed, 31 Dec 2025 13:11:14 GMT]]></title><description><![CDATA[<p dir="auto">Der har åbenbart været anlagt sag af konkurrenter, fordi de ikke mente, at Semaglutid var tilstrækkeligt opfindsomt og at der ikke var tilstrækkeligt data til at understøtte det. En retsinstans var faktisk enig i dette i 2022.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988249</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988249</guid><dc:creator><![CDATA[Craw]]></dc:creator><pubDate>Wed, 31 Dec 2025 13:11:14 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Wed, 31 Dec 2025 12:56:01 GMT]]></title><description><![CDATA[<p dir="auto">Ja jeg syns os det en underlig mail?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988242</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988242</guid><dc:creator><![CDATA[Zuunes]]></dc:creator><pubDate>Wed, 31 Dec 2025 12:56:01 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Wed, 31 Dec 2025 12:49:35 GMT]]></title><description><![CDATA[<p dir="auto">Jeg har læst teksten og er alligevel ikke klar over, hvad denne positive beslutning består i? Jeg tænker ikke, at Kina pludselig har forlænget Novos patent på Semaglutid? Også da der ikke står nogen om, hvor meget den så skulle blive forlænget. Er det bare en bekræftelse<br />
på den patent man allerede havde?</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988248</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988248</guid><dc:creator><![CDATA[Craw]]></dc:creator><pubDate>Wed, 31 Dec 2025 12:49:35 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Wed, 31 Dec 2025 12:45:28 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk A/S: China’s Supreme People’s Court delivers a positive ruling on the semaglutide compound patent<br />
December 31, 2025 08:24 ET | Source: Novo Nordisk A/Shttps://www.globenewswire.com/news-release/2025/12/31/3211779/0/en/Novo-Nordisk-A-S-China-s-Supreme-People-s-Court-delivers-a-positive-ruling-on-the-semaglutide-compound-patent.html</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988246</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988246</guid><dc:creator><![CDATA[Jan_H]]></dc:creator><pubDate>Wed, 31 Dec 2025 12:45:28 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Wed, 31 Dec 2025 10:56:16 GMT]]></title><description><![CDATA[<p dir="auto">FDA har godkendt en opdatering af Mounjaro (tirzepatide) til også at inkludere behandling af type 2-diabetes hos børn og unge fra 10 år og opefter, som et supplement til kost og motion. <a href="https://pi.lilly.com/us/mounjaro-uspi.pdf" rel="nofollow ugc">https://pi.lilly.com/us/mounjaro-uspi.pdf</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988243</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988243</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 31 Dec 2025 10:56:16 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Wed, 31 Dec 2025 09:09:23 GMT]]></title><description><![CDATA[<p dir="auto">God formiddag og godt nytår til alle. Stor tak til alle de dygtige skribenter og alle deres indsigtsfulde bidrag i årets løb:-)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988244</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988244</guid><dc:creator><![CDATA[JKY_VH]]></dc:creator><pubDate>Wed, 31 Dec 2025 09:09:23 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Wed, 31 Dec 2025 09:01:56 GMT]]></title><description><![CDATA[<p dir="auto">En lille opdatering på mit emne omkring produktion af semaglotid fra aug/sept. :<br />
<a href="https://proinvestor.com/boards/130534" rel="nofollow ugc">https://proinvestor.com/boards/130534</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988241</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988241</guid><dc:creator><![CDATA[Alberto]]></dc:creator><pubDate>Wed, 31 Dec 2025 09:01:56 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Wed, 31 Dec 2025 06:30:04 GMT]]></title><description><![CDATA[<p dir="auto">Enig Alberto. Det er en god artikel. <img src="https://dev.proinvestor.com/forum/assets/plugins/nodebb-plugin-emoji/emoji/android/1f642.png?v=ace6278a214" class="not-responsive emoji emoji-android emoji--slightly_smiling_face" style="height:23px;width:auto;vertical-align:middle" title=":-)" alt="🙂" /></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988240</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988240</guid><dc:creator><![CDATA[Helge_LarsenPI-redaktør]]></dc:creator><pubDate>Wed, 31 Dec 2025 06:30:04 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Tue, 30 Dec 2025 15:38:52 GMT]]></title><description><![CDATA[<p dir="auto">“The signal was always in the prevention space rather than the treatment space,” he added. Interessant artikel, som bla. har fokus på muligheder for semaglodtide i Altheimers... Som vi jo har snakket om herinde: Som forebyg</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988239</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988239</guid><dc:creator><![CDATA[Alberto]]></dc:creator><pubDate>Tue, 30 Dec 2025 15:38:52 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Tue, 30 Dec 2025 09:03:55 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk’s ‘long game’ on weight loss drugs sparks hope in science, but the Street is impatient <a href="https://www.cnbc.com/2025/12/30/novo-nordisk-beyond-weight-loss-has-investors-wary-scientists-hopeful.html?utm_campaign=trueanthem&amp;utm_content=main&amp;utm_medium=social&amp;utm_source=linkedin" rel="nofollow ugc">https://www.cnbc.com/2025/12/30/novo-nordisk-beyond-weight-loss-has-investors-wary-scientists-hopeful.html?utm_campaign=trueanthem&amp;utm_content=main&amp;utm_medium=social&amp;utm_source=linkedin</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988245</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988245</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 30 Dec 2025 09:03:55 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Tue, 30 Dec 2025 08:34:17 GMT]]></title><description><![CDATA[<p dir="auto">Første kommercielle video på Wegovy pillen: <a href="https://www.ispot.tv/ad/gVcy/ww-the-new-wegovy-pill" rel="nofollow ugc">https://www.ispot.tv/ad/gVcy/ww-the-new-wegovy-pill</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988238</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988238</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 30 Dec 2025 08:34:17 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Tue, 30 Dec 2025 06:24:37 GMT]]></title><description><![CDATA[<p dir="auto">Novo-rival skærer i priserne på vægttabsmedicin i Kina <a href="https://proinvestor.com/investornyt/1398348/novo-rival-skaerer-i-priserne-pa-vaegttabsmedicin-i-kina" rel="nofollow ugc">https://proinvestor.com/investornyt/1398348/novo-rival-skaerer-i-priserne-pa-vaegttabsmedicin-i-kina</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988236</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988236</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 30 Dec 2025 06:24:37 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Tue, 30 Dec 2025 05:14:58 GMT]]></title><description><![CDATA[<p dir="auto">Kort video..</p>
<p dir="auto">I denne nytårsspecial fokuserer Helge Larsen på de mest populære selskaber på <a href="http://ProInvestor.com" rel="nofollow ugc">ProInvestor.com</a> inden for fedmesektoren og giver sit bud på, hvordan det kommende år tegner for dem hver især. <a href="https://proinvestor.com/boards/130518" rel="nofollow ugc">https://proinvestor.com/boards/130518</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988233</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988233</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Tue, 30 Dec 2025 05:14:58 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Mon, 29 Dec 2025 22:18:10 GMT]]></title><description><![CDATA[<p dir="auto">Hele videoen er interessant</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988234</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988234</guid><dc:creator><![CDATA[pauly]]></dc:creator><pubDate>Mon, 29 Dec 2025 22:18:10 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Mon, 29 Dec 2025 22:16:49 GMT]]></title><description><![CDATA[<p dir="auto">Grækenland har åbenbart sat et program i søen hvor 30.000 over bmi 40 får tilbudt behandling med vægttabsmedicin <a href="https://www.youtube.com/watch?v=JtvVy7h3d8A" rel="nofollow ugc">https://www.youtube.com/watch?v=JtvVy7h3d8A</a> (29:30)</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988229</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988229</guid><dc:creator><![CDATA[pauly]]></dc:creator><pubDate>Mon, 29 Dec 2025 22:16:49 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Mon, 29 Dec 2025 15:13:37 GMT]]></title><description><![CDATA[<p dir="auto">Vi gør status over 2025 og ser frem mod de største investeringsmuligheder i 2026. Få en skarp analyse af Trump-faktoren, Novo Nordisk og udsigterne for danske aktier i det nye år, og bliv klar som investor til 2026 i afsnit 304 af Investeringspodcasten. Video: <a href="https://proinvestor.com/boards/130517" rel="nofollow ugc">https://proinvestor.com/boards/130517</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988232</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988232</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 29 Dec 2025 15:13:37 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Mon, 29 Dec 2025 10:05:55 GMT]]></title><description><![CDATA[<p dir="auto">Finwire: Danska läkemedelsbolaget Novo Nordisk har halverat listpriserna på fetmaläkemedlet Wegovy i vissa kinesiska provinser inför väntad konkurrens från kopior. Det rapporterar Yicai, enligt Bloomberg News.</p>
<p dir="auto">I provinserna Yunnan och Sichuan ska priserna ha sänkts för de två högsta doserna till 987,48 respektive 1 284,36 yuan, motsvarande 1 290 och 1 675 kronor.</p>
<p dir="auto">Bolaget citeras ha sagt till Yicai att sänkningen ska minska patienternas kostnader och förbättra följsamheten i behandlingen.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988235</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988235</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 29 Dec 2025 10:05:55 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Mon, 29 Dec 2025 08:37:51 GMT]]></title><description><![CDATA[<p dir="auto">Novo forsøger at begrænse eksport af russisk Ozempic-kopi <a href="https://proinvestor.com/investornyt/1398020/novo-forsoger-at-begraense-eksport-af-russisk-ozempic-kopi" rel="nofollow ugc">https://proinvestor.com/investornyt/1398020/novo-forsoger-at-begraense-eksport-af-russisk-ozempic-kopi</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988230</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988230</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 29 Dec 2025 08:37:51 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Mon, 29 Dec 2025 06:59:36 GMT]]></title><description><![CDATA[<p dir="auto">Novos anbefaling og kursmål løftes hos Baptista <a href="https://proinvestor.com/investornyt/1398003/novos-anbefaling-og-kursmal-loftes-hos-baptista" rel="nofollow ugc">https://proinvestor.com/investornyt/1398003/novos-anbefaling-og-kursmal-loftes-hos-baptista</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988237</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988237</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 29 Dec 2025 06:59:36 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Mon, 29 Dec 2025 05:31:46 GMT]]></title><description><![CDATA[<p dir="auto">Novo: Amerikanske sygekasser er klar til billigere vægttabsmedicin <a href="https://proinvestor.com/investornyt/1397998/novo-amerikanske-sygekasser-er-klar-til-billigere-vaegttabsmedicin" rel="nofollow ugc">https://proinvestor.com/investornyt/1397998/novo-amerikanske-sygekasser-er-klar-til-billigere-vaegttabsmedicin</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988231</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988231</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Mon, 29 Dec 2025 05:31:46 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Sun, 28 Dec 2025 10:52:18 GMT]]></title><description><![CDATA[<p dir="auto"></p><div class="ratio ratio-16x9">
<iframe src="https://www.youtube-nocookie.com/embed/cgu-XOhE5k8" title="YouTube video player" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share; fullscreen"></iframe>
</div><p></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988225</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988225</guid><dc:creator><![CDATA[Jan_H]]></dc:creator><pubDate>Sun, 28 Dec 2025 10:52:18 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Sun, 28 Dec 2025 10:52:11 GMT]]></title><description><![CDATA[<p dir="auto">Dette er USA"s fedeste by.</p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988226</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988226</guid><dc:creator><![CDATA[Jan_H]]></dc:creator><pubDate>Sun, 28 Dec 2025 10:52:11 GMT</pubDate></item><item><title><![CDATA[Reply to NOVO — December 2025 on Sat, 27 Dec 2025 11:55:28 GMT]]></title><description><![CDATA[<p dir="auto">Novo Nordisk annoteret kursgraf <a href="https://proinvestor.com/boards/130495" rel="nofollow ugc">https://proinvestor.com/boards/130495</a></p>
]]></description><link>https://dev.proinvestor.com/forum/post/7988224</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/7988224</guid><dc:creator><![CDATA[ProinvestorNEWS]]></dc:creator><pubDate>Sat, 27 Dec 2025 11:55:28 GMT</pubDate></item></channel></rss>